Janney Montgomery Scott’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.58M Sell
10,383
-34,117
-77% -$5.18M ﹤0.01% 1325
2025
Q1
$6.7M Buy
44,500
+5,148
+13% +$775K 0.02% 670
2024
Q4
$7.26M Sell
39,352
-5,634
-13% -$1.04M 0.02% 651
2024
Q3
$8.86M Sell
44,986
-47
-0.1% -$9.26K 0.02% 570
2024
Q2
$9.3M Sell
45,033
-973
-2% -$201K 0.03% 531
2024
Q1
$12.5M Buy
46,006
+2,300
+5% +$623K 0.04% 457
2023
Q4
$10.3M Sell
43,706
-1,225
-3% -$290K 0.03% 494
2023
Q3
$8.81M Sell
44,931
-675
-1% -$132K 0.03% 483
2023
Q2
$9.59M Buy
45,606
+3,498
+8% +$735K 0.03% 479
2023
Q1
$8.5M Buy
42,108
+986
+2% +$199K 0.03% 474
2022
Q4
$8.96M Sell
41,122
-2,496
-6% -$544K 0.03% 472
2022
Q3
$8.58M Buy
43,618
+206
+0.5% +$40.5K 0.04% 439
2022
Q2
$9.3M Sell
43,412
-84
-0.2% -$18K 0.04% 380
2022
Q1
$12.4M Buy
43,496
+4,499
+12% +$1.28M 0.05% 323
2021
Q4
$14.7M Buy
38,997
+3,201
+9% +$1.21M 0.06% 300
2021
Q3
$14.8M Buy
35,796
+988
+3% +$408K 0.06% 273
2021
Q2
$12.9M Buy
34,808
+1,772
+5% +$655K 0.06% 299
2021
Q1
$9.58M Buy
33,036
+2,461
+8% +$713K 0.05% 342
2020
Q4
$7.64M Buy
30,575
+2,189
+8% +$547K 0.04% 404
2020
Q3
$6.43M Buy
28,386
+1,446
+5% +$327K 0.04% 402
2020
Q2
$4.7M Buy
26,940
+3,270
+14% +$570K 0.03% 475
2020
Q1
$2.99M Sell
23,670
-452
-2% -$57K 0.02% 550
2019
Q4
$3.69M Sell
24,122
-1,678
-7% -$256K 0.02% 567
2019
Q3
$3.42M Buy
25,800
+7,261
+39% +$961K 0.02% 562
2019
Q2
$2.63M Buy
18,539
+18
+0.1% +$2.56K 0.02% 621
2019
Q1
$2.69M Buy
18,521
+1,540
+9% +$224K 0.02% 601
2018
Q4
$1.92M Sell
16,981
-1,163
-6% -$132K 0.02% 656
2018
Q3
$2.44M Buy
+18,144
New +$2.44M 0.02% 640
2018
Q1
Sell
-6,213
Closed -$680K 1948
2017
Q4
$680K Sell
6,213
-214
-3% -$23.4K 0.01% 1146
2017
Q3
$694K Buy
+6,427
New +$694K 0.01% 1096